CD Formulation, a company with extensive experience in detecting nucleic acid preparations, offers digital droplet polymerase chain reaction (ddPCR) technology to accurately and quantitatively identify point mutations in samples, particularly in complex, rare, and valuable specimens.
Droplet Digital PCR (ddPCR) is a digital PCR technology that employs a water-oil emulsion droplet system. This method operates on the principle that a PCR sample is partitioned into approximately 20,000 water-in-oil droplets using a microtitration process facilitated by a microtitre generator. In this system, nucleic acid molecules are randomly distributed among a vast number of individual droplets, with each droplet containing either one or no nucleic acid molecules to be detected.
After PCR, each droplet is analyzed to determine the proportion of PCR-positive droplets in the original sample. This data is then evaluated using Poisson statistics to ascertain the concentration of the target DNA template in the original sample.
Fig.1 Sample processing and droplet digital PCR workflow. (Zhang W, et al., 2023)
A PCR reaction system is prepared by mixing extracted nucleic acids with primers, probes, dNTPs, a buffer, and DNA polymerase.
The reaction mixture is dispensed into a microtiter generator, which creates thousands of tiny reaction cavities using a water-in-oil emulsion. Each of these microdroplets may contain either zero or one target molecule.
PCR amplification of microdroplets in a thermal cycler typically involves three steps: denaturation, annealing, and extension.
A ddPCR instrument is utilized to detect the fluorescence signal in each microdroplet. By analyzing the fluorescence intensity, it can be determined whether each microdroplet contains the target nucleic acid, thereby facilitating digital quantitative analysis.
The fluorescence signals in the droplets are subjected to statistical analysis. The actual concentration of target nucleic acid molecules is quantified by counting the number of positive (fluorescent) and negative (non-fluorescent) droplets, using the Poisson distribution model as a reference.
Primers and probes must be designed with a high degree of specificity to ensure that only the target sequence is amplified and detected, thereby minimizing errors and interference.
The selection of primers and probes significantly influences the sensitivity of the experiment. High-quality primers and probes can detect very low concentrations of the target sequence, enabling the experiment to reliably identify rare mutations or low-abundance targets.
Efficient primers and probes enhance the success rate and yield of PCR reactions, while stable primers and probes guarantee reproducible and reliable results.
CD Formulation's ddPCR technology platforms have significant applications in the bioanalysis of nucleic acid drugs. Our platforms offer absolute quantitative measurements that minimize errors associated with standard curves and replication dependencies.
Technology: Droplet digital PCR (ddPCR) technology for tuberculosis detection
Journal: Microorganisms
IF: 4.926
Published: 2020
Results:
Droplet digital PCR (ddPCR) is a recently developed third-generation PCR that overcomes the challenges of fluorescence-based real-time quantitative PCR (qPCR) for absolute quantification of pathogens. In the present study, the steps for developing and evaluating a duplex single-dye (FAM) assay for the detection of two targets were clearly described using both simplex and duplex experiments. For this purpose, various parameters including annealing temperature, primer and probe concentrations, sensitivity and specificity, sample concentration, and inter/intra-assay variability were investigated. The results showed that primer and probe concentration, annealing temperature and sample concentration had an effect on droplet position and separation in both simplex and duplex assays. The specificity and sensitivity of the ddPCR assay was 100% compared to qPCR.
Fig.2 Overview of the droplet digital PCR (ddPCR) assay workflow. (Nyaruaba R, et al., 2020)
CD Formulation's ddPCR technology platform offers a highly sensitive and quantitatively accurate method for analyzing low-abundance nucleic acid molecules. Contact us to customize a professional solution tailored to your project.
References